Document Detail


Exercise-induced ischemia in the streptokinase-reperfused myocardium: relationship to extent of salvaged myocardium and degree of residual coronary stenosis.
MedLine Citation:
PMID:  2741799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess the functional significance of residual stenosis at the site of the thrombolysed infarct-related coronary artery, 37 patients underwent exercise radionuclide ventriculography or stress-redistribution thallium-201 scintigraphy at an average of 7 weeks following streptokinase therapy during evolving myocardial infarction. The size of the initially jeopardized myocardium and the salvaged myocardium were quantitated on thallium-201 studies obtained immediately before and 10 days after streptokinase infusion. Exercise-induced ischemia (defined by reversible thallium-201 perfusion defects or stress-induced deterioration of regional wall motion) in the reperfused myocardium was absent in 46% of patients and was present in different degrees in the remaining 54%. A significantly lower proportion of patients, however, showed exercise-induced chest pain and/or ST segment depression (10% and 20%, respectively). By stepwise multiple logistic regression analysis, the quantitatively determined size of the salvaged myocardium (398 units versus 65 units, p less than 0.01) and the ratio of the salvaged myocardium/extent of initially jeopardized myocardium (70% versus 28%, p less than 0.01) were both independent predictors of stress-induced ischemia, whereas the extent of initially jeopardized myocardium (585 units versus 407 units, p = NS), incidence of greater than or equal to 99% coronary stenosis (37% versus 46%, p = NS), and ischemic time (160 versus 196 minutes, p = NS) did not provide additional predictive information. We conclude that exercise-induced ischemia, which is frequently present in the streptokinase-reperfused myocardium, cannot be detected accurately by exercise-induced chest pain or ST segment depression, nor can it be predicted by the severity of residual coronary stenosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A T Weiss; J Maddahi; P K Shah; A S Lew; H J Swan; W Ganz; D S Berman
Related Documents :
17067689 - Time course of motor behavior changes in mongolian gerbils submitted to different durat...
22452709 - A standard blood bank donation alters the thermal and cardiovascular responses during s...
1849909 - Eeg suppression and anoxic depolarization: influences on cerebral oxygenation during is...
25419939 - Patient readiness to exercise after cardiac surgery: development of the readiness to ch...
2801969 - Role of leukocytes in reperfusion injury of skeletal muscle after partial ischemia.
11090839 - Cardiotrophin-1 protects the human myocardium from ischemic injury. comparison with the...
9140669 - Comparison of sweat rate measured by a pouch collector and a hygrometric technique duri...
9836319 - A review of research on physical exercise with people with severe and profound developm...
6538829 - Various coagulation techniques tested in a rabbit model. results of morphological and e...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  118     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1989 Jul 
Date Detail:
Created Date:  1989-08-01     Completed Date:  1989-08-01     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  9-16     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Constriction, Pathologic
Coronary Circulation
Coronary Vessels / pathology*
Female
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy*,  pathology,  physiopathology
Myocardial Reperfusion
Myocardium / pathology*
Physical Exertion*
Streptokinase / therapeutic use*
Grant Support
ID/Acronym/Agency:
17651//PHS HHS
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Radiofrequency ablation of ventricular myocardium using active fixation and passive contact catheter...
Next Document:  Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of lef...